Canadian Pharmaceuticals & Biotech High Insider Buying

Bright Minds Biosciences

Market Cap: CA$1.1b

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Vector Science and Therapeutics

Market Cap: CA$340.9m

Develops and sells novel biomechanical devices and active localized drug-delivery platforms.

Auxly Cannabis Group

Market Cap: CA$309.0m

Operates as a consumer-packaged goods company in the cannabis products market in Canada.

Satellos Bioscience

Market Cap: CA$278.7m

A clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia.

Organigram Global

Market Cap: CA$237.9m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

HLS Therapeutics

Market Cap: CA$122.0m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.

ME Therapeutics Holdings

Market Cap: CA$76.0m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

Decibel Cannabis

Market Cap: CA$63.5m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

Sona Nanotech

Market Cap: CA$44.2m

Operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor targeting activity, anti-bacterial activity, and drug delivery vehicle, as well as diagnostics, such as diagnostic markers for imaging and immunoassay and biosensing.

Medicenna Therapeutics

Market Cap: CA$42.5m

A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.

Microbix Biosystems

Market Cap: CA$41.1m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

Thiogenesis Therapeutics

Market Cap: CA$38.5m

A clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs.

Optimi Health

Market Cap: CA$38.1m

Operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.

Voyageur Pharmaceuticals

Market Cap: CA$36.2m

Engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah.

Avicanna

Market Cap: CA$18.1m

A commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for medical and pharmaceutical markets in Canada and internationally.

1CM

Market Cap: CA$17.1m

A multi-jurisdictional cannabis company, retails cannabis, alcohol, tobacco, nicotine, and consumer packaged goods in Canada.

Medicure

Market Cap: CA$14.2m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

Marvel Biosciences

Market Cap: CA$10.7m

A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.

Blueberries Medical

Market Cap: CA$7.4m

A consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia.

Kane Biotech

Market Cap: CA$6.2m

A biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally.

Innovotech

Market Cap: CA$4.6m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

Restart Life Sciences

Market Cap: CA$4.4m

Through its subsidiaries, operates as a biotechnology company in Canada.

Grey Matters Health

Market Cap: CA$4.0m

Operates as a clinical stage pharmaceutical development company in Canada, the United States, and Australia.

Rakovina Therapeutics

Market Cap: CA$3.7m

A biopharmaceutical research company, engages in the research and development of cancer treatments that target DNA-damage response systems.

Delivra Health Brands

Market Cap: CA$3.1m

Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.